{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-003052","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.665689+00:00","generated_at":"2026-06-02T17:44:55.762529+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Paysign Q1 revenue $13.2M (+30% YoY); net income $309k vs loss; reaffirms FY guidance","bullets":["Total revenue $13.2M, up 30% YoY; net income $309k ($0.01 diluted EPS) vs net loss $160k in Q1 2023.","Adjusted EBITDA $1.7M, up 135% from $720k; diluted adj. EBITDA per share $0.03 vs $0.01.","Pharma patient affordability revenue surged 305% YoY; added 10 net new programs, ending quarter with 53 active.","Plasma revenue up 11% YoY; 469 plasma centers (net +5); avg revenue per center per month $7,414 (+5%).","Confirms FY 2024 guidance: revenue $54.5M–$56.7M, adjusted EBITDA $8.0M–$9.0M; Q2 revenue expected +27.5% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-003052","json":"https://secwatch.observer/filing/0001683168-24-003052.json","markdown":"https://secwatch.observer/filing/0001683168-24-003052.md","text":"https://secwatch.observer/filing/0001683168-24-003052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824003052/0001683168-24-003052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824003052/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T17:44:55.762529+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b73e8291d8841ec4004856bfa8da01163bfd5700","claim":"Paysign, Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $13.2 million, net income $309 thousand, EPS $0.01.","evidence_excerpt":"First quarter 2024 total revenues of $13.2 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824003052/0001683168-24-003052-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended March 31, 2024"},{"label":"Revenue","value":"$13.2 million"},{"label":"Net income","value":"$309 thousand"},{"label":"EPS","value":"$0.01"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}